Mammalian cell technology finds extensive use in pharmaceutical and biotechnology companies, academic research institutions, and regenerative medicine. Currently, North America dominates the market, followed by Europe and the Asia Pacific region. Key players such as Lonza Group, Thermo Fisher Scientific, and Merck KGaA hold prominent market positions through product innovation and strategic collaborations.